213 related articles for article (PubMed ID: 11437496)
1. Increased level of soluble HLA class I antigens in systemic lupus erythematosus: correlation with anti-DNA antibodies and leukopenia.
Kippner L; Klint C; Sturfelt G; Bengtsson AA; Eriksson H; Truedsson L
J Autoimmun; 2001 Jun; 16(4):471-8. PubMed ID: 11437496
[TBL] [Abstract][Full Text] [Related]
2. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus.
Hagihara M; Shimura T; Yamamoto K; Sujirachato K; Tsuji S; Yamamura M; Tsuji K
Tokai J Exp Clin Med; 1993 Jun; 18(1-2):61-4. PubMed ID: 7940609
[TBL] [Abstract][Full Text] [Related]
4. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC
Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679
[TBL] [Abstract][Full Text] [Related]
5. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
[TBL] [Abstract][Full Text] [Related]
6. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
Mok CC; Ho LY; Leung HW; Wong LG
Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
[TBL] [Abstract][Full Text] [Related]
9. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
10. Correlation of serum measures of nitric oxide production with lupus disease activity.
Gilkeson G; Cannon C; Oates J; Reilly C; Goldman D; Petri M
J Rheumatol; 1999 Feb; 26(2):318-24. PubMed ID: 9972965
[TBL] [Abstract][Full Text] [Related]
11. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
Su Y; Jia RL; Han L; Li ZG
Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
Nguyen CP; Cao VV; Fehér J; Gergely P
Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
[TBL] [Abstract][Full Text] [Related]
13. Expression of human leukocyte antigen-G in systemic lupus erythematosus.
Rosado S; Perez-Chacon G; Mellor-Pita S; Sanchez-Vegazo I; Bellas-Menendez C; Citores MJ; Losada-Fernandez I; Martin-Donaire T; Rebolleda N; Perez-Aciego P
Hum Immunol; 2008 Jan; 69(1):9-15. PubMed ID: 18295670
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinemia in males with systemic lupus erythematosus.
Mok CC; Lau CS; Lee KW; Wong RW
J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
Heshmat NM; El-Kerdany TH
Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
Morgan PE; Sturgess AD; Davies MJ
Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
[TBL] [Abstract][Full Text] [Related]
17. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q.
Bengtsson A; Nezlin R; Shoenfeld Y; Sturfelt G
J Autoimmun; 1999 Aug; 13(1):111-9. PubMed ID: 10441175
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
[TBL] [Abstract][Full Text] [Related]
19. Correlation between clinical activity and serological markers in a wide cohort of patients with systemic lupus erythematosus: an eight-year prospective study.
Villegas-Zambrano N; Martínez-Taboada VM; Bolívar A; San Martín M; Alvarez L; Marín MJ; López-Hoyos M
Ann N Y Acad Sci; 2009 Sep; 1173():60-6. PubMed ID: 19758133
[TBL] [Abstract][Full Text] [Related]
20. Soluble HLA-G in rheumatoid arthritis.
Verbruggen LA; Rebmann V; Demanet C; De Cock S; Grosse-Wilde H
Hum Immunol; 2006 Aug; 67(8):561-7. PubMed ID: 16916651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]